Geode Capital Management
BHST

Geode Capital Management’s BioHarvest Sciences BHST Stock Holding History

Geode Capital Management’s Portfolio BHST Stock Details BHST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.8K Sell
10,558
-1,253
-11% -$4.78K ﹤0.01% 4330
2026
Q1 		$51.3K Hold
11,811
– – ﹤0.01% 4307
2025
Q4 		$61.3K Buy
+11,811
New +$94.4K ﹤0.01% 4201

Other funds holding BHST

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return
EWM
Evercore Wealth Management New York $7.07B AUM 24.72% 1-Year Est. Return
TNA
True North Advisors Dallas, Texas $1.05B AUM 22.99% 1-Year Est. Return
MFG
Magnus Financial Group New York $1.41B AUM 23.4% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $24.4B AUM 22.19% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Geode Capital Management's BHST Position: Q2 2026 in Review

Geode Capital Management reduced its BioHarvest Sciences (BHST) stake by 11% in Q2 2026, selling an estimated $4.78K and leaving 10,558 shares worth $29.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4330.

Geode Capital Management first reported a position in BHST in Q4 2025 and has held it in 3 quarters since. The position peaked at $61.3K in Q4 2025. 19 funds tracked by Wall St. Rank hold BHST as of Q2 2026.

  • Geode Capital Management held 10,558 shares of BioHarvest Sciences worth $29.8K as of Q2 2026.
  • Geode Capital Management sold 1,253 BioHarvest Sciences shares in Q2 2026, an estimated $4.78K.
  • BioHarvest Sciences made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #4330 holding.
  • Geode Capital Management first reported a position in BioHarvest Sciences in Q4 2025 and has held it in 3 quarters since.
  • Geode Capital Management's BioHarvest Sciences position peaked at $61.3K in Q4 2025.
  • 19 funds tracked by Wall St. Rank held BioHarvest Sciences as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.